Neuroimmunology < Neuroleptic < Neuroleptic Malignant Syndrome (classification)

Facettes :

List of bibliographic references indexed by Neuroleptic

Number of relevant bibliographic references: 78.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
001684 (2011)	Richard A. Walsh [Canada] ; Anthony E. Lang [Canada]	Early‐onset tardive dyskinesia in a neuroleptic‐naive patient exposed to low‐dose quetiapine
001863 (2011)	Maria Sierra Pena [États-Unis] ; Toby C. Yaltho [États-Unis] ; Joseph Jankovic [États-Unis]	Tardive Dyskinesia and Other Movement Disorders Secondary to Aripiprazole
001888 (2011)	Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
001F30 (2010)	P. Ken Gillman [Australie] ; Mrc Psych [Australie]	Neuroleptic Malignant Syndrome: Mechanisms, Interactions, and Causality
002007 (2009)	Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]	Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
002092 (2009)	Susanne A. Schneider [Royaume-Uni] ; Vrajesh Udani [Inde] ; Charulata Sawant Sankhla [Inde] ; Kailash P. Bhatia [Royaume-Uni]	Recurrent acute dystonic reaction and oculogyric crisis despite withdrawal of dopamine receptor blocking drugs
003274 (2006)	Mattia Gambarin [Italie] ; Angelo Antonini [Italie] ; Giuseppe Moretto [Italie] ; Paolo Bovi [Italie] ; Silvia Romito [Italie] ; Antonio Fiaschi [Italie] ; Michele Tinazzi [Italie]	Pisa syndrome without neuroleptic exposure in a patient with Parkinson's disease: Case report
003420 (2006)	Katie Kompoliti [États-Unis] ; Christopher G. Goetz [États-Unis] ; Mary Morrissey [États-Unis] ; Sue Leurgans [États-Unis]	Gilles de la Tourette syndrome: Patient's knowledge and concern of adverse effects
003447 (2006)	Daniel Tarsy [États-Unis] ; Ross J. Baldessarini [États-Unis]	Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?
003830 (2005)	Jong-Hoon Kim [Corée du Sud] ; Young-Ho Jin [Corée du Sud] ; Ung Gu Kang [Corée du Sud] ; Yong Min Ahn [Corée du Sud] ; Kyoo-Seob Ha [Corée du Sud] ; Yong Sik Kim [Corée du Sud]	Neuroleptic‐induced acute and chronic akathisia: A clinical comparison
003849 (2005)	Nicte I. Mejia [États-Unis] ; Joseph Jankovic [États-Unis]	Metoclopramide‐induced tardive dyskinesia in an infant
003F17 (2003)	Anjan Chatterjee [États-Unis] ; Steven J. Frucht [États-Unis]	Tetrabenazine in the treatment of severe pediatric chorea
003F81 (2003)	Werner Poewe [Autriche]	Psychosis in Parkinson's disease
004048 (2003)	Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis]	Long‐term outcome of quetiapine use for psychosis among parkinsonian patients
004262 (2002)	Sujana Reddy [États-Unis] ; Stewart A. Factor [États-Unis] ; Eric S. Molho [États-Unis] ; Paul J. Feustel [États-Unis]	The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia
004366 (2002)	William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]	Olanzapine treatment for dopaminergic‐induced hallucinations
004534 (2002)	Theresa A. Zesiewicz [États-Unis] ; Sujatha Borra [États-Unis] ; Robert A. Hauser [États-Unis]	Clozapine withdrawal symptoms in a Parkinson's disease patient
004661 (2001)	Han-Cheng Wang [Taïwan] ; Yoloung Hsieh [Taïwan]	Treatment of neuroleptic malignant syndrome with subcutaneous apomorphine monotherapy
004742 (2001)	P. H. Gordon [États-Unis] ; S. J. Frucht [États-Unis]	Neuroleptic malignant syndrome in advanced Parkinson's disease
004841 (2001)	Stewart A. Factor [États-Unis] ; Joseph H. Friedman [États-Unis] ; Margaret C. Lannon [États-Unis] ; David Oakes [États-Unis] ; Keith Bourgeois [États-Unis]	Clozapine for the treatment of drug‐induced psychosis in Parkinson's disease: Results of the 12 week open label extension in the PSYCLOPS trial
004968 (2000)	Norman A. Leopold [États-Unis]	Risperidone treatment of drug‐related psychosis in patients with parkinsonism

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Neuroleptic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Neuroleptic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Neuroleptic
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024